<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC7363568</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC7363568.2</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">7363568</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">7482440</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">32522711</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1016/j.nbd.2020.104960</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">S0969-9961(20)30235-7</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">104960</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Baseline sample characteristics.</table-caption><table-wrap-foot>NfL = Neurofilament light chain; EYO = estimated years from expected symptom onset; MMSE = Mini-Mental State Examination.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p>Baseline sample characteristics.</p></caption><alt-text id="al0030">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Characteristic</th><th colspan="1" rowspan="1">Non-carrier (<italic toggle="yes">N</italic> = 84)</th><th colspan="1" rowspan="1">Mutation-carrier (<italic toggle="yes">N</italic> = 117)</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age (yrs), mean (SD)</td><td colspan="1" rowspan="1">40.5 (10.7)</td><td colspan="1" rowspan="1">38.6 (10.8)</td><td colspan="1" rowspan="1">.230</td></tr><tr><td colspan="1" rowspan="1">Sex, female (%)</td><td colspan="1" rowspan="1">58.3</td><td colspan="1" rowspan="1">50.8</td><td colspan="1" rowspan="1">.293</td></tr><tr><td colspan="1" rowspan="1">Years of Education, mean (SD)</td><td colspan="1" rowspan="1">14.5 (3.2)</td><td colspan="1" rowspan="1">14.1 (3.2)</td><td colspan="1" rowspan="1">.492</td></tr><tr><td colspan="1" rowspan="1">Body Mass Index, mean (SD)</td><td colspan="1" rowspan="1">28.8 (6.0)</td><td colspan="1" rowspan="1">30.2 (24.2)</td><td colspan="1" rowspan="1">.601</td></tr><tr><td colspan="1" rowspan="1"><xref rid="tf0005" ref-type="table-fn">a</xref>Hypertension, %</td><td colspan="1" rowspan="1">16.7</td><td colspan="1" rowspan="1">6.8</td><td colspan="1" rowspan="1">.080</td></tr><tr><td colspan="1" rowspan="1"><xref rid="tf0005" ref-type="table-fn">a</xref>Diabetes, %</td><td colspan="1" rowspan="1">2.4</td><td colspan="1" rowspan="1">0.0</td><td colspan="1" rowspan="1">.230</td></tr><tr><td colspan="1" rowspan="1">Serum NfL (pg/mL), mean (SD)</td><td colspan="1" rowspan="1">23.7 (12.5)</td><td colspan="1" rowspan="1">33.4 (23.1)</td><td colspan="1" rowspan="1">.001</td></tr><tr><td colspan="1" rowspan="1">EYO (yrs), mean (SD)</td><td colspan="1" rowspan="1">–</td><td colspan="1" rowspan="1">-8.5 (11.0)</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">MMSE, mean (SD)</td><td colspan="1" rowspan="1">29.2 (1.2)</td><td colspan="1" rowspan="1">27.2 (4.1)</td><td colspan="1" rowspan="1">&lt;.001</td></tr><tr><td colspan="1" rowspan="1">Clinical Dementia Rating, 0, 0.5, ≥ 1, <italic toggle="yes">n</italic> (%)</td><td colspan="1" rowspan="1">81 (96.4), 3 (3.6), 0 (0)</td><td colspan="1" rowspan="1">76 (65.0), 32 (27.4), 9 (7.6)</td><td colspan="1" rowspan="1">&lt;.001</td></tr></tbody></table><table-wrap-foot><fn><p>NfL = Neurofilament light chain; EYO = estimated years from expected symptom onset; MMSE = Mini-Mental State Examination.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0005"><label>a</label><p id="np0005">Percent of individuals currently receiving active management and/or medication for disease.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Baseline sample characteristics.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Non-carrier (N = 84)</th><th>Mutation-carrier (N = 117)</th><th>p-Value</th></tr></thead><tbody><tr><td>Age (yrs), mean (SD)</td><td>40.5 (10.7)</td><td>38.6 (10.8)</td><td>.230</td></tr><tr><td>Sex, female (%)</td><td>58.3</td><td>50.8</td><td>.293</td></tr><tr><td>Years of Education, mean (SD)</td><td>14.5 (3.2)</td><td>14.1 (3.2)</td><td>.492</td></tr><tr><td>Body Mass Index, mean (SD)</td><td>28.8 (6.0)</td><td>30.2 (24.2)</td><td>.601</td></tr><tr><td>???Hypertension, %</td><td>16.7</td><td>6.8</td><td>.080</td></tr><tr><td>???Diabetes, %</td><td>2.4</td><td>0.0</td><td>.230</td></tr><tr><td>Serum NfL (pg/mL), mean (SD)</td><td>23.7 (12.5)</td><td>33.4 (23.1)</td><td>.001</td></tr><tr><td>EYO (yrs), mean (SD)</td><td>–</td><td>-8.5 (11.0)</td><td>–</td></tr><tr><td>MMSE, mean (SD)</td><td>29.2 (1.2)</td><td>27.2 (4.1)</td><td>&lt;.001</td></tr><tr><td>Clinical Dementia Rating, 0, 0.5, ≥ 1, n (%)</td><td>81 (96.4), 3 (3.6), 0 (0)</td><td>76 (65.0), 32 (27.4), 9 (7.6)</td><td>&lt;.001</td></tr></tbody></table></div>NfL = Neurofilament light chain; EYO = estimated years from expected symptom onset; MMSE = Mini-Mental State Examination.aPercent of individuals currently receiving active management and/or medication for disease.</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>Main effect of serum NfL on DTI metrics in MC.</table-caption><table-wrap-foot>Unstandardized regression coefficient B and adjusted p-values for serum NfL from a series of linear mixed effect models in each ROI, which included random intercepts for family, and fixed effects for age, sex, and NfL. Dependent variables were the average WM metrics (FA, MD, DA, and DR) from each ROI. N = 117. WM = White matter; NfL = Neurofilament light chain; ROI = region of interest; SE = standard error.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p>Main effect of serum NfL on DTI metrics in MC.</p></caption><alt-text id="al0035">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">WM tract</th><th colspan="2" rowspan="1">Fractional anisotropy<hr/></th><th colspan="2" rowspan="1">Mean diffusivity<hr/></th><th colspan="2" rowspan="1">Axial diffusivity<hr/></th><th colspan="2" rowspan="1">Radial diffusivity<hr/></th></tr><tr><th colspan="1" rowspan="1">B (SE)</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th colspan="1" rowspan="1">B (SE)</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th colspan="1" rowspan="1">B (SE)</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th colspan="1" rowspan="1">B (SE)</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Inferior Longitudinal Fasciculus</td><td colspan="1" rowspan="1">−0.062 (0.01)</td><td colspan="1" rowspan="1">1.41E-06</td><td colspan="1" rowspan="1">0.090 (0.02)</td><td colspan="1" rowspan="1">1.61E-05</td><td colspan="1" rowspan="1">0.065 (0.02)</td><td colspan="1" rowspan="1">.0077</td><td colspan="1" rowspan="1">0.102 (0.02)</td><td colspan="1" rowspan="1">1.50E-06</td></tr><tr><td colspan="1" rowspan="1">Superior Longitudinal Fasciculus</td><td colspan="1" rowspan="1">−0.048 (0.01)</td><td colspan="1" rowspan="1">.00020</td><td colspan="1" rowspan="1">0.091 (0.02)</td><td colspan="1" rowspan="1">1.34E-06</td><td colspan="1" rowspan="1">0.090 (0.02)</td><td colspan="1" rowspan="1">2.71E-05</td><td colspan="1" rowspan="1">0.094 (0.02)</td><td colspan="1" rowspan="1">4.46E-06</td></tr><tr><td colspan="1" rowspan="1">Frontal Occipital Fasciculus</td><td colspan="1" rowspan="1">−0.071 (0.01)</td><td colspan="1" rowspan="1">1.54E-09</td><td colspan="1" rowspan="1">0.108 (0.02)</td><td colspan="1" rowspan="1">8.03E-09</td><td colspan="1" rowspan="1">0.084 (0.02)</td><td colspan="1" rowspan="1">2.32E-05</td><td colspan="1" rowspan="1">0.124 (0.02)</td><td colspan="1" rowspan="1">6.52E-10</td></tr><tr><td colspan="1" rowspan="1">Perforant Pathway</td><td colspan="1" rowspan="1">−0.106 (0.02)</td><td colspan="1" rowspan="1">5.28E-07</td><td colspan="1" rowspan="1">0.150 (0.02)</td><td colspan="1" rowspan="1">6.78E-08</td><td colspan="1" rowspan="1">0.084 (0.04)</td><td colspan="1" rowspan="1">.0193</td><td colspan="1" rowspan="1">0.162 (0.03)</td><td colspan="1" rowspan="1">6.40E-09</td></tr><tr><td colspan="1" rowspan="1">Uncinate Fasciculus</td><td colspan="1" rowspan="1">−0.047 (0.01)</td><td colspan="1" rowspan="1">4.73E-05</td><td colspan="1" rowspan="1">0.060 (0.02)</td><td colspan="1" rowspan="1">.00019</td><td colspan="1" rowspan="1">0.037 (0.02)</td><td colspan="1" rowspan="1">.0398</td><td colspan="1" rowspan="1">0.071 (0.02)</td><td colspan="1" rowspan="1">3.34E-05</td></tr><tr><td colspan="1" rowspan="1">Cingulum</td><td colspan="1" rowspan="1">−0.088 (0.02)</td><td colspan="1" rowspan="1">7.80E-08</td><td colspan="1" rowspan="1">0.133 (0.02)</td><td colspan="1" rowspan="1">3.69E-09</td><td colspan="1" rowspan="1">0.091 (0.03)</td><td colspan="1" rowspan="1">.00123</td><td colspan="1" rowspan="1">0.153 (0.02)</td><td colspan="1" rowspan="1">1.93E-10</td></tr><tr><td colspan="1" rowspan="1">Frontal Aslant</td><td colspan="1" rowspan="1">−0.060 (0.01)</td><td colspan="1" rowspan="1">9.83E-08</td><td colspan="1" rowspan="1">0.089 (0.02)</td><td colspan="1" rowspan="1">4.51E-05</td><td colspan="1" rowspan="1">0.088 (0.03)</td><td colspan="1" rowspan="1">.00197</td><td colspan="1" rowspan="1">0.101 (0.02)</td><td colspan="1" rowspan="1">6.29E-06</td></tr><tr><td colspan="1" rowspan="1">Corticospinal</td><td colspan="1" rowspan="1">−0.027 (0.01)</td><td colspan="1" rowspan="1">.012</td><td colspan="1" rowspan="1">0.032 (0.02)</td><td colspan="1" rowspan="1">.0689</td><td colspan="1" rowspan="1">0.007 (0.03)</td><td colspan="1" rowspan="1">.785</td><td colspan="1" rowspan="1">0.042 (0.02)</td><td colspan="1" rowspan="1">.00826</td></tr><tr><td colspan="1" rowspan="1">Anterior Corpus Callosum</td><td colspan="1" rowspan="1">−0.119 (0.02)</td><td colspan="1" rowspan="1">3.10E-06</td><td colspan="1" rowspan="1">0.284 (0.04)</td><td colspan="1" rowspan="1">4.31E-10</td><td colspan="1" rowspan="1">0.301 (0.06)</td><td colspan="1" rowspan="1">4.52E-07</td><td colspan="1" rowspan="1">0.279 (0.04)</td><td colspan="1" rowspan="1">7.20E-09</td></tr><tr><td colspan="1" rowspan="1">Posterior Corpus Callosum</td><td colspan="1" rowspan="1">−0.155 (0.02)</td><td colspan="1" rowspan="1">4.26E-10</td><td colspan="1" rowspan="1">0.321 (0.04)</td><td colspan="1" rowspan="1">1.83E-12</td><td colspan="1" rowspan="1">0.276 (0.06)</td><td colspan="1" rowspan="1">3.76E-06</td><td colspan="1" rowspan="1">0.344 (0.04)</td><td colspan="1" rowspan="1">8.09E-12</td></tr><tr><td colspan="1" rowspan="1">Forceps Minor</td><td colspan="1" rowspan="1">−0.074 (0.01)</td><td colspan="1" rowspan="1">1.10E-08</td><td colspan="1" rowspan="1">0.099 (0.02)</td><td colspan="1" rowspan="1">1.60E-07</td><td colspan="1" rowspan="1">0.086 (0.02)</td><td colspan="1" rowspan="1">.000364</td><td colspan="1" rowspan="1">0.114 (0.02)</td><td colspan="1" rowspan="1">1.24E-08</td></tr><tr><td colspan="1" rowspan="1">Forceps Major</td><td colspan="1" rowspan="1">−0.087 (0.01)</td><td colspan="1" rowspan="1">4.77E-09</td><td colspan="1" rowspan="1">0.122 (0.02)</td><td colspan="1" rowspan="1">2.24E-08</td><td colspan="1" rowspan="1">0.082 (0.02)</td><td colspan="1" rowspan="1">.000109</td><td colspan="1" rowspan="1">0.146 (0.02)</td><td colspan="1" rowspan="1">3.14E-09</td></tr></tbody></table><table-wrap-foot><fn><p>Unstandardized regression coefficient B and adjusted <italic toggle="yes">p</italic>-values for serum NfL from a series of linear mixed effect models in each ROI, which included random intercepts for family, and fixed effects for age, sex, and NfL. Dependent variables were the average WM metrics (FA, MD, DA, and DR) from each ROI. <italic toggle="yes">N</italic> = 117. WM = White matter; NfL = Neurofilament light chain; ROI = region of interest; SE = standard error.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Main effect of serum NfL on DTI metrics in MC.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">WM tract</th><th colspan="2">Fractional anisotropy</th><th colspan="2">Mean diffusivity</th><th colspan="2">Axial diffusivity</th><th colspan="2">Radial diffusivity</th></tr><tr><th>B (SE)</th><th>p</th><th>B (SE)</th><th>p</th><th>B (SE)</th><th>p</th><th>B (SE)</th><th>p</th></tr></thead><tbody><tr><td>Inferior Longitudinal Fasciculus</td><td>−0.062 (0.01)</td><td>1.41E-06</td><td>0.090 (0.02)</td><td>1.61E-05</td><td>0.065 (0.02)</td><td>.0077</td><td>0.102 (0.02)</td><td>1.50E-06</td></tr><tr><td>Superior Longitudinal Fasciculus</td><td>−0.048 (0.01)</td><td>.00020</td><td>0.091 (0.02)</td><td>1.34E-06</td><td>0.090 (0.02)</td><td>2.71E-05</td><td>0.094 (0.02)</td><td>4.46E-06</td></tr><tr><td>Frontal Occipital Fasciculus</td><td>−0.071 (0.01)</td><td>1.54E-09</td><td>0.108 (0.02)</td><td>8.03E-09</td><td>0.084 (0.02)</td><td>2.32E-05</td><td>0.124 (0.02)</td><td>6.52E-10</td></tr><tr><td>Perforant Pathway</td><td>−0.106 (0.02)</td><td>5.28E-07</td><td>0.150 (0.02)</td><td>6.78E-08</td><td>0.084 (0.04)</td><td>.0193</td><td>0.162 (0.03)</td><td>6.40E-09</td></tr><tr><td>Uncinate Fasciculus</td><td>−0.047 (0.01)</td><td>4.73E-05</td><td>0.060 (0.02)</td><td>.00019</td><td>0.037 (0.02)</td><td>.0398</td><td>0.071 (0.02)</td><td>3.34E-05</td></tr><tr><td>Cingulum</td><td>−0.088 (0.02)</td><td>7.80E-08</td><td>0.133 (0.02)</td><td>3.69E-09</td><td>0.091 (0.03)</td><td>.00123</td><td>0.153 (0.02)</td><td>1.93E-10</td></tr><tr><td>Frontal Aslant</td><td>−0.060 (0.01)</td><td>9.83E-08</td><td>0.089 (0.02)</td><td>4.51E-05</td><td>0.088 (0.03)</td><td>.00197</td><td>0.101 (0.02)</td><td>6.29E-06</td></tr><tr><td>Corticospinal</td><td>−0.027 (0.01)</td><td>.012</td><td>0.032 (0.02)</td><td>.0689</td><td>0.007 (0.03)</td><td>.785</td><td>0.042 (0.02)</td><td>.00826</td></tr><tr><td>Anterior Corpus Callosum</td><td>−0.119 (0.02)</td><td>3.10E-06</td><td>0.284 (0.04)</td><td>4.31E-10</td><td>0.301 (0.06)</td><td>4.52E-07</td><td>0.279 (0.04)</td><td>7.20E-09</td></tr><tr><td>Posterior Corpus Callosum</td><td>−0.155 (0.02)</td><td>4.26E-10</td><td>0.321 (0.04)</td><td>1.83E-12</td><td>0.276 (0.06)</td><td>3.76E-06</td><td>0.344 (0.04)</td><td>8.09E-12</td></tr><tr><td>Forceps Minor</td><td>−0.074 (0.01)</td><td>1.10E-08</td><td>0.099 (0.02)</td><td>1.60E-07</td><td>0.086 (0.02)</td><td>.000364</td><td>0.114 (0.02)</td><td>1.24E-08</td></tr><tr><td>Forceps Major</td><td>−0.087 (0.01)</td><td>4.77E-09</td><td>0.122 (0.02)</td><td>2.24E-08</td><td>0.082 (0.02)</td><td>.000109</td><td>0.146 (0.02)</td><td>3.14E-09</td></tr></tbody></table></div>Unstandardized regression coefficient B and adjusted p-values for serum NfL from a series of linear mixed effect models in each ROI, which included random intercepts for family, and fixed effects for age, sex, and NfL. Dependent variables were the average WM metrics (FA, MD, DA, and DR) from each ROI. N = 117. WM = White matter; NfL = Neurofilament light chain; ROI = region of interest; SE = standard error.</transformed-table></extracted-table></extracted-tables-set>